Schalken JA - Search Results

1

Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.

Benoist GE, van Oort IM, Boerrigter E, Verhaegh GW, van Hooij O, Groen L, Smit F, de Mol P, Hamberg P, Dezentjé VO, Mehra N, Gerritsen W, Somford DM, van Erp NPH, Schalken JA. Benoist GE, et al. Among authors: schalken ja. Clin Chem. 2020 Jun 1;66(6):842-851. doi: 10.1093/clinchem/hvaa095. Clin Chem. 2020. PMID: 32408351

2

Differential expression of vimentin in rat prostatic tumors.

Bussemakers MJ, Verhaegh GW, van Bokhoven A, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1254-9. doi: 10.1016/0006-291x(92)91866-o. Biochem Biophys Res Commun. 1992. PMID: 1540169

3

The genes for the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome.

Bussemakers MJ, van Bokhoven A, Völler M, Smit FP, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Biochem Biophys Res Commun. 1994 Sep 15;203(2):1291-4. doi: 10.1006/bbrc.1994.2322. Biochem Biophys Res Commun. 1994. PMID: 8093046

4

p16 mutations/deletions are not frequent events in prostate cancer.

Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Debruyne FM, Schalken JA. Tamimi Y, et al. Among authors: schalken ja. Br J Cancer. 1996 Jul;74(1):120-2. doi: 10.1038/bjc.1996.325. Br J Cancer. 1996. PMID: 8679444 Free PMC article.

5

Homozygous deletions of p16(INK4) occur frequently in bilharziasis-associated bladder cancer.

Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Abbas A, Debruyne FM, Schalken JA. Tamimi Y, et al. Among authors: schalken ja. Int J Cancer. 1996 Oct 9;68(2):183-7. doi: 10.1002/(SICI)1097-0215(19961009)68:2<183::AID-IJC7>3.0.CO;2-U. Int J Cancer. 1996. PMID: 8900425 Free article.

6

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. Bussemakers MJ, et al. Among authors: schalken ja. Cancer Res. 1999 Dec 1;59(23):5975-9. Cancer Res. 1999. PMID: 10606244

7

Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene.

Verhaegh GW, van Bokhoven A, Smit F, Schalken JA, Bussemakers MJ. Verhaegh GW, et al. Among authors: schalken ja. J Biol Chem. 2000 Dec 1;275(48):37496-503. doi: 10.1074/jbc.M006293200. J Biol Chem. 2000. PMID: 10982808 Free article.

8

DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.

de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA. de Kok JB, et al. Among authors: schalken ja. Cancer Res. 2002 May 1;62(9):2695-8. Cancer Res. 2002. PMID: 11980670

9

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. Hessels D, et al. Among authors: schalken ja. Eur Urol. 2003 Jul;44(1):8-15; discussion 15-6. doi: 10.1016/s0302-2838(03)00201-x. Eur Urol. 2003. PMID: 12814669

10

New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.

Schalken JA, Hessels D, Verhaegh G. Schalken JA, et al. Urology. 2003 Nov;62(5 Suppl 1):34-43. doi: 10.1016/s0090-4295(03)00759-3. Urology. 2003. PMID: 14607216 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters